Search Results - "Marks, I."

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation by Galleu, Antonio, Riffo-Vasquez, Yanira, Trento, Cristina, Lomas, Cara, Dolcetti, Luigi, Cheung, Tik Shing, von Bonin, Malte, Barbieri, Laura, Halai, Krishma, Ward, Sophie, Weng, Ling, Chakraverty, Ronjon, Lombardi, Giovanna, Watt, Fiona M, Orchard, Kim, Marks, David I, Apperley, Jane, Bornhauser, Martin, Walczak, Henning, Bennett, Clare, Dazzi, Francesco

“…The immunosuppressive activity of mesenchymal stromal cells (MSCs) is well documented. However, the therapeutic benefit is completely unpredictable, thus…”
Get more information

Molecular genetics and targeted therapeutics in biliary tract carcinoma by Marks, Eric I, Yee, Nelson S

“…The primary malignancies of the biliary tract, cholangiocarcinoma and gallbladder cancer, often present at an advanced stage and are marginally sensitive to…”
Get full text

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia by Fielding, Adele K., Rowe, Jacob M., Buck, Georgina, Foroni, Letizia, Gerrard, Gareth, Litzow, Mark R., Lazarus, Hillard, Luger, Selina M., Marks, David I., McMillan, Andrew K., Moorman, Anthony V., Patel, Bella, Paietta, Elisabeth, Tallman, Martin S., Goldstone, Anthony H.

“…The Philadelphia chromosome positive arm of the UKALLXII/ECOG2993 study for adult acute lymphoblastic leukemia (ALL) enrolled 266 patients between 1993 and…”
Get full text

Recovery of a top predator mediates negative eutrophic effects on seagrass by Hughes, Brent B., Eby, Ron, Van Dyke, Eric, Tinker, M. Tim, Marks, Corina I., Johnson, Kenneth S., Wasson, Kerstin

“…A fundamental goal of the study of ecology is to determine the drivers of habitat-forming vegetation, with much emphasis given to the relative importance to…”
Get full text

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) by Giebel, Sebastian, Marks, David I., Boissel, Nicolas, Baron, Frederic, Chiaretti, Sabina, Ciceri, Fabio, Cornelissen, Jan J., Doubek, Michael, Esteve, Jordi, Fielding, Adele, Foa, Robin, Gorin, Norbert-Claude, Gökbuget, Nicola, Hallböök, Helene, Hoelzer, Dieter, Paravichnikova, Elena, Ribera, Josep-Maria, Savani, Bipin, Rijneveld, Anita W., Schmid, Christoph, Wartiovaara-Kautto, Ulla, Mohty, Mohamad, Nagler, Arnon, Dombret, Hervé

“…Allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission is a standard of care for adult patients with Philadelphia chromosome…”
Get full text

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis by Eapen, Mary, MD, Rocha, Vanderson, MD, Sanz, Guillermo, MD, Scaradavou, Andromachi, MD, Zhang, Mei-Jie, Prof, Arcese, William, Prof, Sirvent, Anne, MD, Champlin, Richard E, Prof, Chao, Nelson, Prof, Gee, Adrian P, Prof, Isola, Luis, MD, Laughlin, Mary J, MD, Marks, David I, Prof, Nabhan, Samir, MD, Ruggeri, Annalisa, MD, Soiffer, Robert, Prof, Horowitz, Mary M, Prof, Gluckman, Eliane, Prof, Wagner, John E, Prof

“…Summary Background Umbilical-cord blood (UCB) is increasingly considered as an alternative to peripheral blood progenitor cells (PBPCs) or bone marrow,…”
Get full text

Evaluating the collection, comparability and findings of six global surgery indicators by Holmer, H., Bekele, A., Hagander, L., Harrison, E. M., Kamali, P., Ng‐Kamstra, J. S., Khan, M. A., Knowlton, L., Leather, A. J. M., Marks, I. H., Meara, J. G., Shrime, M. G., Smith, M., Søreide, K., Weiser, T. G., Davies, J.

“…Background In 2015, six indicators were proposed to evaluate global progress towards access to safe, affordable and timely surgical and anaesthesia care…”
Get full text

Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia by Kantarjian, Hagop M., Su, Yun, Jabbour, Elias J., Bhattacharyya, Helen, Yan, Eric, Cappelleri, Joseph C., Marks, David I.

“…BACKGROUND Inotuzumab ozogamicin (InO), an anti‐CD22 antibody‐calicheamicin conjugate, demonstrated superior clinical activity versus standard‐of‐care (SOC)…”
Get full text

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure by DUVAL, Michel, KLEIN, John P, KEATING, Armand, LAZARUS, Hillard M, LITZOW, Mark R, MARKS, David I, MAZIARZ, Richard T, RIZZIERI, David A, SCHILLER, Gary, SCHULTZ, Kirk R, TALLMAN, Martin S, WEISDORF, Daniel, WENSHENG HE, CAHN, Jean-Yves, CAIRO, Mitchell, CAMITTA, Bruce M, KAMBLE, Rammurti, COPELAN, Edward, DE LIMA, Marcos, GUPTA, Vikas

“…Patients with acute leukemia refractory to induction or reinduction chemotherapy have poor prognoses if they do not undergo hematopoietic stem-cell…”
Get full text

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease by Bachanova, V, Marks, D I, Zhang, M-J, Wang, H, de Lima, M, Aljurf, M D, Arellano, M, Artz, A S, Bacher, U, Cahn, J-Y, Chen, Y-B, Copelan, E A, Drobyski, W R, Gale, R P, Greer, J P, Gupta, V, Hale, G A, Kebriaei, P, Lazarus, H M, Lewis, I D, Lewis, V A, Liesveld, J L, Litzow, M R, Loren, A W, Miller, A M, Norkin, M, Oran, B, Pidala, J, Rowe, J M, Savani, B N, Saber, W, Vij, R, Waller, E K, Wiernik, P H, Weisdorf, D J

“…The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Philadelphia chromosome positive (Ph+) acute…”
Get full text

Computer-aided psychotherapy: revolution or bubble? by Marks, I. M., Cavanagh, K., Gega, L.

“…Research into computer-aided psychotherapy is thriving around the world. Most of it concerns computer-aided cognitive–behavioural therapy (CCBT). A recent…”
Get full text

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation by Marks, David I., Pagliuca, Antonio, Kibbler, Christopher C., Glasmacher, Axel, Heussel, Claus‐Peter, Kantecki, Michal, Miller, Paul J.S., Ribaud, Patricia, Schlamm, Haran T., Solano, Carlos, Cook, Gordon

“…Summary Antifungal prophylaxis for allogeneic haematopoietic stem‐cell transplant (alloHCT) recipients should prevent invasive mould and yeast infections…”
Get full text

Barriers to Women Entering Surgical Careers: A Global Study into Medical Student Perceptions by Marks, I. H., Diaz, A., Keem, M., Ladi-Seyedian, Seyedeh-Sanam, Philipo, G. S., Munir, H., Pomerani, T. I., Sughayer, H. M., Peter, N., Lavy, C., Chang, D. C.

“…Background Barriers to female surgeons entering the field are well documented in Australia, the USA and the UK, but how generalizable these problems are to…”
Get full text

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study by Fielding, Adele K., Richards, Susan M., Chopra, Rajesh, Lazarus, Hillard M., Litzow, Mark R., Buck, Georgina, Durrant, I. Jill, Luger, Selina M., Marks, David I., Franklin, Ian M., McMillan, Andrew K., Tallman, Martin S., Rowe, Jacob M., Goldstone, Anthony H.

“…Most adults with acute lymphoblastic leukemia (ALL) who achieve complete remission (CR) will relapse. We examined the outcome of 609 adults with recurring ALL,…”
Get full text

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies by Olsson, R F, Logan, B R, Chaudhury, S, Zhu, X, Akpek, G, Bolwell, B J, Bredeson, C N, Dvorak, C C, Gupta, V, Ho, V T, Lazarus, H M, Marks, D I, Ringdén, O T H, Pasquini, M C, Schriber, J R, Cooke, K R

“…Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis ( n =23 272) which investigates means to…”
Get full text

Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma by Marks, Eric I, Yee, Nelson S

“…Hepatocellular carcinoma (HCC) is a highly lethal disease, therefore effective and tolerable treatment is urgently needed. In this article, we provide an…”
Get more information

GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes by Chen, Y-B, Wang, T, Hemmer, M T, Brady, C, Couriel, D R, Alousi, A, Pidala, J, Urbano-Ispizua, A, Choi, S W, Nishihori, T, Teshima, T, Inamoto, Y, Wirk, B, Marks, D I, Abdel-Azim, H, Lehmann, L, Yu, L, Bitan, M, Cairo, M S, Qayed, M, Salit, R, Gale, R P, Martino, R, Jaglowski, S, Bajel, A, Savani, B, Frangoul, H, Lewis, I D, Storek, J, Askar, M, Kharfan-Dabaja, M A, Aljurf, M, Ringden, O, Reshef, R, Olsson, R F, Hashmi, S, Seo, S, Spitzer, T R, MacMillan, M L, Lazaryan, A, Spellman, S R, Arora, M, Cutler, C S

“…Using the Center for International Blood and Marrow Transplant Research (CIBMTR) registry, we analyzed 1404 umbilical cord blood transplantation (UCBT)…”
Get full text

Does injection of botulinum toxin to salivary glands require ultrasound guidance? by Marks, I.H., Ridgley Vaidya, J., Israel, O., Nixon, P., Sharma, R.

“…Injection of botulinum toxin into salivary glands is a well-established treatment for sialorrhea in children, but the absolute need for radiological guidance…”
Get full text

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis by Williams, K M, Ahn, K W, Chen, M, Aljurf, M D, Agwu, A L, Chen, A R, Walsh, T J, Szabolcs, P, Boeckh, M J, Auletta, J J, Lindemans, C A, Zanis-Neto, J, Malvezzi, M, Lister, J, de Toledo Codina, J S, Sackey, K, Chakrabarty, J L H, Ljungman, P, Wingard, J R, Seftel, M D, Seo, S, Hale, G A, Wirk, B, Smith, M S, Savani, B N, Lazarus, H M, Marks, D I, Ustun, C, Abdel-Azim, H, Dvorak, C C, Szer, J, Storek, J, Yong, A, Riches, M R

“…Pneumocystis jiroveci pneumonia (PJP) is associated with high morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Little is known…”
Get full text

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials by Creasey, Thomas, Barretta, Emilio, Ryan, Sarra L, Butler, Ellie, Kirkwood, Amy A, Leongamornlert, Daniel, Papaemmanuil, Elli, Patrick, Pip, Clifton-Hadley, Laura, Patel, Bela, Menne, Tobias, McMillan, Andrew K, Harrison, Christine J, Rowntree, Clare J, Morley, Nick, Marks, David I, Fielding, Adele K, Moorman, Anthony V

“…Despite being predominantly a childhood disease, the incidence of acute lymphoblastic leukemia (ALL) has a second peak in adults aged 60 years and over. These…”
Get full text